Prnewswire is writing a great story about the new Kardia Mobile 6L, which will be available in the summer. Kardia Mobile has already received the third FDA approval within three months. The new Kardia Mobile will be the world's first six-cable ECG device. It provides patients and physicians with even greater insight into patients' hearts, including the visibility of certain arrhythmias, which are cardiovascular disease indicators.
"KardiaMobile 6L is the most clinically valuable personal ECG ever created, and another important step in AliveCor's path to making cardiac care as comfortable, accessible and cost-effective as never before," said Ira Bahr, CEO of AliveCor.
"KardiaMobile 6L is the most clinically valuable personal ECG ever created, and another important step in AliveCor's path to making cardiac care as comfortable, accessible and cost-effective as never before," said Ira Bahr, CEO of AliveCor.
